Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) — Cash Flow-to-Debt Ratio
Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of CN¥117.38 Million could theoretically repay 0% of its total liabilities (CN¥2.44 Billion) in one year. See financial flexibility index of Zhangzhou Pientzehuang Pharmaceutical Co to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2001–2025)
Historical debt coverage capacity for Zhangzhou Pientzehuang Pharmaceutical Co Ltd across 25 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Zhangzhou Pientzehuang Pharmaceutical Co.
Annual Cash Flow-to-Debt Ratio for Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2001–2025)
Year-by-year debt coverage analysis for Zhangzhou Pientzehuang Pharmaceutical Co Ltd. Check 600436 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.03x | CN¥77.03 Million | CN¥2.47 Billion | ▼ -93.6% |
| 2024 | 0.49x | CN¥1.31 Billion | CN¥2.70 Billion | ▼ -30.3% |
| 2023 | 0.70x | CN¥2.21 Billion | CN¥3.16 Billion | ▼ -71.8% |
| 2022 | 2.47x | CN¥6.87 Billion | CN¥2.78 Billion | ▲ +1161.5% |
| 2021 | 0.20x | CN¥462.27 Million | CN¥2.36 Billion | ▼ -74.0% |
| 2020 | 0.75x | CN¥1.47 Billion | CN¥1.95 Billion | ▲ +257.6% |
| 2019 | -0.48x | CN¥-879.37 Million | CN¥1.84 Billion | ▼ -205.3% |
| 2018 | 0.45x | CN¥612.31 Million | CN¥1.35 Billion | ▼ -18.1% |
| 2017 | 0.55x | CN¥676.93 Million | CN¥1.22 Billion | ▲ +80.6% |
| 2016 | 0.31x | CN¥394.54 Million | CN¥1.29 Billion | ▼ -24.6% |
| 2015 | 0.41x | CN¥305.51 Million | CN¥751.60 Million | ▲ +1.8% |
| 2014 | 0.40x | CN¥264.50 Million | CN¥662.34 Million | ▼ -2.9% |
| 2013 | 0.41x | CN¥274.34 Million | CN¥667.05 Million | ▲ +71.0% |
| 2012 | 0.24x | CN¥162.40 Million | CN¥675.22 Million | ▼ -60.8% |
| 2011 | 0.61x | CN¥232.95 Million | CN¥379.69 Million | ▲ +8.4% |
| 2010 | 0.57x | CN¥205.41 Million | CN¥362.97 Million | ▲ +86.7% |
| 2009 | 0.30x | CN¥129.52 Million | CN¥427.35 Million | ▲ +667.6% |
| 2008 | 0.04x | CN¥12.57 Million | CN¥318.45 Million | ▼ -86.1% |
| 2007 | 0.28x | CN¥60.04 Million | CN¥212.03 Million | ▼ -38.8% |
| 2006 | 0.46x | CN¥50.70 Million | CN¥109.53 Million | ▼ -42.6% |
| 2005 | 0.81x | CN¥69.06 Million | CN¥85.56 Million | ▼ -83.9% |
| 2004 | 5.01x | CN¥98.67 Million | CN¥19.69 Million | ▲ +541.1% |
| 2003 | 0.78x | CN¥32.36 Million | CN¥41.40 Million | ▲ +26.7% |
| 2002 | 0.62x | CN¥105.45 Million | CN¥170.99 Million | ▲ +16.5% |
| 2001 | 0.53x | CN¥65.84 Million | CN¥124.34 Million | — |